Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sans

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Brain Imaging and Behavior|October 13, 2020
Functional connectivity alterations associated with literacy difficulties in early readersRoger Mateu-Estivill, Susanna Forné, Anna López-Sala, et al.
Journal of Inherited Metabolic Disease|September 21, 2010
Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disordersElisa De Grandis, Mercedes Serrano, Belén Pérez-Dueñas, et al.
Actas Espanolas De Psiquiatria|February 4, 2015
Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)José A Alda, César Soutullo, Josep A Ramos-Quiroga, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Brain Imaging and Behavior|October 13, 2020
Functional connectivity alterations associated with literacy difficulties in early readersRoger Mateu-Estivill, Susanna Forné, Anna López-Sala, et al.
Journal of Inherited Metabolic Disease|September 21, 2010
Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disordersElisa De Grandis, Mercedes Serrano, Belén Pérez-Dueñas, et al.
Actas Espanolas De Psiquiatria|February 4, 2015
Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)José A Alda, César Soutullo, Josep A Ramos-Quiroga, et al.
Pageof 2